Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Recombinant Omicron-Delta COVID-19 Vaccine

1 clinical trial

1 indication

Indication
COVID-19
Clinical trial
A Randomized, Open, Positive Controlled Clinical Study to Evaluate the Immunogenicity and Safety of Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell) in People Aged 18 Years and Over
Status: Completed, Estimated PCD: 2022-10-09